Revenue segments as reported by the company.

Subscription services

Professional services and other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

General and admin

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Veeva Systems

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Veeva Systems reports robust Q1 earnings, eyes growth opportunities

Veeva Systems delivered strong financial performance in Q1 2023, driven by robust execution and competitive wins. The company's focus on innovation, AI capabilities, and the transition to Vault CRM presents significant growth opportunities. However, challenges in the funding environment and customer migrations pose potential hurdles.

Veeva exceeds Q2 expectations, anticipates growth in clinical and data business

Veeva's Q2 performance exceeded expectations, leading to an increase in full-year guidance. The company's strengths lie in strong clinical activity, customer wins, and a focus on product excellence. However, challenges include migration costs, competitive landscape considerations, and marketing spend scrutiny. Veeva sees opportunities in M&A, minimal impact from R&D trends, and expansion of Veeva Link.

Veeva Systems surpasses Q3 expectations, eyes clinical data opportunity

Veeva Systems delivered a strong Q3 performance, with solid revenue and operating income. While facing challenges in billings and macroeconomic uncertainties, the company remains confident in its revenue target for fiscal year '25. The commitment from major enterprises and the potential in clinical data present significant opportunities for future growth.

Veeva Systems reports strong Q4 performance and forecasts $2.8B revenue

Veeva Systems showcases strong performance and strategic planning with revenue growth expectations of at least 15% in fiscal '24 and '25.
Positive feedback on product transitions and development, along with specialized sales teams, highlights market acceptance and innovation.
Challenges include short-term revenue impacts from timing-related issues and macro environment effects on customer spending.
Opportunities lie in revenue growth forecasts, product innovation, and market differentiation through new offerings and strategic deals.

Veeva Systems reports robust Q1 revenue growth and strategic focus

Veeva Systems' Q1 performance reflects strong revenue growth and a focus on customer-centric innovation. The company faces challenges in project scrutiny and competition but has opportunities in new product monetization and segment expansion.

Veeva Systems excels in Q2, eyes disciplined growth and innovation

Veeva Systems showcased robust financial performance, exceeding revenue and operating income targets, with a strong focus on customer success and product excellence.
While facing challenges such as migration costs and regulatory impacts, Veeva is well-positioned to leverage opportunities in disciplined M&A and product innovation.
The company's strategic growth initiatives, including Veeva Link expansion and CRM platform enhancements, aim to drive continued success and value for customers.

Veeva Systems posts solid Q3 results, eyes growth opportunities

Veeva Systems delivered a strong Q3 performance with solid revenue and operating income, showcasing financial stability and growth potential.
Despite challenges like trimmed billings and deal delays, Veeva remains confident in its fiscal year '25 revenue target, emphasizing strategic focus and operational efficiency.
The company's strengths in innovative products, strong partnerships, and global support ecosystem position it well for future growth and market leadership.
Opportunities in customer migration, AI integration, and market demand present avenues for Veeva to drive revenue growth and enhance its competitive positioning in the industry.

Veeva Systems excels in Q4 earnings, poised for strategic growth

Veeva Systems delivered strong financial performance in Q4 2024, showcasing revenue growth, operating income efficiency, and strategic product advancements.
The company's focus on innovation, customer success, and disciplined financial guidance positions it well for future growth and market leadership.
While facing challenges related to market uncertainties and operational considerations, Veeva remains resilient and poised to capitalize on opportunities for expansion and differentiation.
Overall, Veeva's Q4 earnings call highlights a balanced approach to growth, operational excellence, and strategic decision-making in a dynamic business environment.

Veeva Systems beats Q1 guidance, lowers full-year outlook amid challenges

Veeva Systems had a strong start to the year, exceeding Q1 guidance but lowering full-year revenue outlook due to macro challenges.
The company's performance in margin, client adoption, and innovation remains robust, with a focus on stability and predictability amidst industry challenges.
Challenges include AI disruption impacting plans, lower revenue guidance, and delays in funding benefits due to global conflicts and interest rate sensitivity.
Opportunities lie in new client bases, EDC deals progress, and the potential growth of Vault Basics and Link products in the market.

Veeva Systems excels in Q2, eyes strategic growth opportunities

Veeva Systems delivered a strong Q2 performance with revenue of $676 million and non-GAAP operating income of $280 million, driven by product expansions and customer wins.
The company's strengths lie in its comprehensive clinical suite, customer comfort with CRM solutions, and the importance of professional services for customer success.
Challenges include short-term billing growth constraints and the need for continuous product excellence, while opportunities exist in data architecture enhancement and upcoming Investor Day insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Veeva Systems Inc. VEEV, -2.18% shares fluctuated between slight gains and losses in the extended session Tuesday after the life-sciences cloud-software company's results and outlook topped Wall Street estimates.

Veeva stock flattish as results, outlook beat Street view

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2021. “It was a transformational year for life sciences and for Veeva. The industry delivered breakthroughs in diagnostics, therapies, and vaccines during a global pandemic,” said CEO Peter Gassner. “I am proud of the Veeva team's execution and commitment. We in

Veeva Announces Fourth Quarter and Fiscal Year 2021 Results

Apple

Amazon

DocuSign

Alphabet

Microsoft

Netflix

ServiceNow

NVIDIA

Palo Alto Networks

Peloton

Tesla

Ternium

Zoom Video

How can you identify the best stocks to buy and watch? By regularly checking IBD stock lists, which have a track record of outperforming the S&P 500.

This Stock List Has Trounced The S&P 19.8% To 1.5% YTD; Here's Why

Ambarella

Big 5 Sporting Goods

Target

These stocks are all up big in the last year but can they keep their momentum in 2021 as the global economy reopens?

This Week's 5 Red-Hot Earnings Charts

Veeva Systems' (VEEV) fiscal fourth-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Veeva Systems (VEEV) to Post Q4 Earnings: What's in Store?

Teladoc

Both tech-related medical stocks have had a phenomenal past 12 months, with shares rising more than 90%. But only one has a solid chance to continue that level of growth in 2021.

Better Buy: Veeva Systems or Teladoc?

A proven strategy and new growth opportunities will help you sleep at night owning this winner.

Where to Invest $10,000 in the Next Market Crash

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Teladoc Health (NYSE: TDOC), Reliq Health Technologies (OTC:RQHTF) (TSX.V:RHT), Relay Medical (CSE: RELA) (OTC: RYMDF) and Veeva Systems (NYSE: VEEV).

HealthTech Trends 2021: CEO's of Teladoc, Reliq Health, Relay Medical and Veeva Systems, Driving Revenue Growth with Innovation and New Markets Expansions

Veeva Systems stock popped up on my radar today as it is showing an implied volatility percentile reading of 83%. This means the current level of implied volatility is higher.

VEEV Stock: How To Trade A Butterfly Spread When Volatility Is High

Disney

MaxLinear

Shoals Technologies Group

Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

These Are The 5 Best Stocks To Buy And Watch Now

CRISPR Therapeutics

Plug Power

Overvalued stocks are easy to find using metrics which indicate a stock should trade for less. But these ones keep bucking their critics.

7 Overvalued Stocks Investors Just Don't Get Tired Of

Salesforce

Which cloud-based CRM company will generate bigger gains in 2021?

Better Buy: Veeva Systems vs. Salesforce

BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) today announced that RB (Reckitt Benckiser), a leading provider of consumer hygiene, health, and nutrition products, is using Veeva CRM and Veeva Vault PromoMats to accelerate its global digital transformation. With Veeva CRM and Vault PromoMats, RB is bringing together multichannel engagement and content to advance its commercial strategy and drive digital excellence around the world. “Veeva CRM and Veeva Vault PromoMats allow us to

Reckitt Benckiser Standardizes on Veeva Commercial Cloud Applications to Advance Digital Excellence Globally

PLEASANTON, Calif.--(BUSINESS WIRE)--Emerging biotechs and enterprise companies are modernizing regulatory information management with Veeva Vault RIM applications.

More Than 250 Companies Transform Regulatory with Veeva Vault RIM Applications

Veeva (VEEV) collaborates with Impel to accelerate the pre-launch planning and digital-first commercial execution for migraine treatment.

Veeva (VEEV) Partners With Impel, Boosts Cloud-Based Offerings

SEATTLE & PLEASANTON, Calif.--(BUSINESS WIRE)--Impel NeuroPharma adopting Veeva software, data, and consulting to accelerate pre-launch planning and digital-first commercial execution.

Impel NeuroPharma Partners With Veeva Systems to Build Integrated, Digital-First Commercial Foundation

PLEASANTON, Calif.--(BUSINESS WIRE)-- #ClinicalResearch--Leading CROs join Veeva Vault CDMS partner program to accelerate study builds and launch higher quality clinical trials.

6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors

It's the first public company ever to do this.

Why I'm Even More Excited to Own Veeva Systems Stock

PLEASANTON, Calif.--(BUSINESS WIRE)--Epredia adopts Veeva Vault Quality and Veeva Vault RIM applications to automate change control between quality management and regulatory operations.

Epredia Adopts Veeva MedTech Solutions to Unify Change Control Across Quality and Regulatory

In the latest trading session, Veeva Systems (VEEV) closed at $292.22, marking a -0.1% move from the previous day.

Veeva Systems (VEEV) Stock Moves -0.1%: What You Should Know

Veeva Systems could double its annual revenue over the next four years.

My Best SaaS Stock for 2021

PayPal

Lululemon Athletica

Pool

See who joins PayPal, Veeva and Lululemon on this screen of Warren Buffett stocks based on the investing strategy of the Berkshire Hathaway CEO. The post Warren Buffett Stocks: Pool Stock, Veeva, PayPal Among 10 Stocks On This Screen appeared first on Investor's Business Daily.

Warren Buffett Stocks: Pool Stock, Veeva, PayPal Among 10 Stocks On This Screen

Agilent Technologies

Baxter

Centene

Walgreens

According to the GuruFocus All-in-One Screener as of Jan. 15, the following Health Care stocks are popular among gurus.

5 Health Care Stocks Gurus Are Buying

Veeva is building the Industry Cloud for the global life sciences industry with solutions including a CRM suite, content and data management, and AI-powered data analytics. In Q3, Veeva reported a revenue growth rate of 34% y/y (acceleration) and a healthy gross margin of 72% (q/q improvement). Veeva is now generating more than $1B a year.

Veeva: Not Enough Risk In This Winning SaaS Platform

BARCELONA, Spain--(BUSINESS WIRE)-- #PBC--In an overwhelming majority vote, 99% of voting shareholders support Veeva's proposal to become a public benefit corporation (PBC).

News for Veeva Systems Stock (VEEV)